Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Hip Int ; 34(2): 221-227, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38414223

ABSTRACT

BACKGROUND AND AIM: Several studies reported osteolysis around polyethylene glycol/polybutylene terephthalate (PEG/PBT) based femoral cement restrictors. Our goal was to evaluate and compare osteolysis around 3 different plug designs: the slow biodegradable PEG/PBT cement restrictor; the fast biodegradable gelatin cement restrictor; and the non-biodegradable polyethylene plug. PATIENTS AND METHODS: In a retrospective multicentre cohort study chart data were extracted of patients who received a total hip arthroplasty between 2008 and 2012. A total of 961 hips were included. Cortical ratio between inner and outer cortices at the centre of the plug was measured on routine postoperative follow-up moments. Median follow up of all 3 hospitals was 3.5 years (1.4-7.3). The primary outcome was evidence of osteolysis (i.e. the difference in cortical ratio [CR]) on anteroposterior (AP) radiographs at final follow-up. RESULTS: Progressive osteolysis was found around the PEG/PBT cement restrictor represented by a significantly increasing cortical ratio (ΔCR 0.067 (95% CI, 0.063-0.071). Distance from tip prosthesis to plug and size of the plug were found to be independent factors in predicting increased cortical ratio. CONCLUSIONS: Our multicentre cohort shows increase of cortical ratio around the PEG/PBT cement restrictor which progresses over time. Physicians should be aware of this fact and are advised to intensify follow-up of patients who received this cement restrictor.


Subject(s)
Arthroplasty, Replacement, Hip , Hip Prosthesis , Osteolysis , Humans , Arthroplasty, Replacement, Hip/adverse effects , Cohort Studies , Osteolysis/chemically induced , Osteolysis/diagnostic imaging , Cementation , Polyethylene , Bone Cements/adverse effects , Hip Prosthesis/adverse effects , Follow-Up Studies , Prosthesis Failure , Prosthesis Design
2.
JBJS Case Connect ; 10(3): e20.00041, 2020.
Article in English | MEDLINE | ID: mdl-32910577

ABSTRACT

CASE: In this case, we report on a carbon-fiber-reinforced polyetheretherketone plate failure 4 months after implantation, radiation therapy, chemotherapy, and protective weight-bearing in a 75-year-old woman who sustained a nontraumatic pathological distal femur fracture due to lymphoma. CONCLUSION: Although carbon-fiber composite implants are regularly used and, to date, there have been no reports of early clinical failures, the longevity of the implant's structural integrity after high-dose radiation and/or chemotherapy treatment has not been fully explored. Therefore, we deem it too early to conclude that carbon-fiber-reinforced polyetheretherketone implants are superior to conventional implants in treating (pathological) fractures.


Subject(s)
Bone Plates/adverse effects , Femoral Fractures/surgery , Fractures, Spontaneous/surgery , Lymphoma/complications , Prosthesis Failure , Aged , Benzophenones , Female , Femoral Fractures/etiology , Fractures, Spontaneous/etiology , Humans , Ketones , Polyethylene Glycols , Polymers
3.
Br J Cancer ; 119(6): 737-743, 2018 09.
Article in English | MEDLINE | ID: mdl-30116026

ABSTRACT

BACKGROUND: Skeletal metastases are a common problem in patients with cancer, and surgical decision making depends on multiple factors including life expectancy. Identification of new prognostic factors can improve survival estimation and guide healthcare providers in surgical decision making. In this study, we aim to determine the prognostic value of neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in patients with bone metastasis. METHODS: One thousand and twelve patients from two tertiary referral centers between 2002 and 2014 met the inclusion criteria. Bivariate and multivariate Cox regression analyses were performed to determine the association of NLR and PLR with survival. RESULTS: At 3 months, 84.0% of the patients with low NLR were alive versus 61.3% of the patients with a high NLR (p < 0.001), and 75.8% of the patients with a low PLR were alive versus 55.6% of the patients with a high PLR (p < 0.001). Both elevated NLR and elevated PLR were independently associated with worse survival (hazard ratio (HR): 1.311; 95% confidence interval (CI): 1.117-1.538; p = 0.001) and (HR: 1.358; 95% CI: 1.152-1.601; p < 0.001), respectively. CONCLUSION: This study showed both NLR and PLR to be independently associated with survival in patients who were treated for skeletal metastasis.


Subject(s)
Bone Neoplasms/blood , Bone Neoplasms/secondary , Neutrophils/cytology , Aged , Bone Neoplasms/pathology , Disease-Free Survival , Female , Humans , Lymphocyte Count , Male , Middle Aged , Platelet Count , Prognosis , Retrospective Studies , Tertiary Care Centers
SELECTION OF CITATIONS
SEARCH DETAIL
...